Natera, Inc. (NTRA): Price and Financial Metrics

Natera, Inc. (NTRA): $85.28

2.00 (-2.29%)

POWR Rating

Component Grades








NTRA Price/Volume Stats

Current price $85.28 52-week high $98.82
Prev. close $87.28 52-week low $36.90
Day low $83.13 Volume 2,526,000
Day high $87.20 Avg. volume 1,480,186
50-day MA $85.61 Dividend yield N/A
200-day MA $61.21 Market Cap 10.30B

NTRA Stock Price Chart Interactive Chart >

Natera, Inc. (NTRA) Company Bio

Natera Inc. is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The company was founded in 2003 and is based in San Carlos, California.

NTRA Latest News Stream

Event/Time News Detail
Loading, please wait...

NTRA Latest Social Stream

Loading social stream, please wait...

View Full NTRA Social Stream

Latest NTRA News From Around the Web

Below are the latest news stories about NATERA INC that investors may wish to consider to help them evaluate NTRA as an investment opportunity.

Natera Wins Preliminary Injunction in Patent Infringement Lawsuit Against NeoGenomics’ RaDaR Test

AUSTIN, Texas, December 28, 2023--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the federal District Court for the Middle District of North Carolina has issued a preliminary injunction, effective immediately, enjoining the RaDaR assay from NeoGenomics Labs, Inc. ("NeoGenomics").

Yahoo | December 28, 2023

13 High Growth Healthcare Stocks to Buy

In this article, we will take a look at 13 high growth healthcare stocks to buy. To skip our analysis of the recent market activity, you can go directly to see the 5 Best High Growth Healthcare Stocks to Buy. For the purpose of this article, we have defined high growth stocks as stocks that […]

Yahoo | December 26, 2023

While Natera (NASDAQ:NTRA) shareholders have made 323% in 5 years, increasing losses might now be front of mind as stock sheds 4.7% this week

Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...

Yahoo | December 21, 2023

Natera Announces New Study Highlighting the Benefits of Signatera’s Unique Method of Quantifying ctDNA

AUSTIN, Texas, December 21, 2023--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in Molecular Oncology comparing the performance of mean tumor molecules per milliliter (MTM/mL) against mean variant allele frequency (mVAF) for measuring circulating tumor DNA (ctDNA), using Signatera™, Natera’s personalized and tumor-informed molecular residual disease (MRD) test. The full study can be found here.

Yahoo | December 21, 2023

Delaware Court Denies CareDx’s Motion for Summary Judgment on Two Natera Patents

AUSTIN, Texas, December 11, 2023--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the United States District Court for the District of Delaware has issued an order denying CareDx’s motion for summary judgment on two Natera patents in the infringement lawsuit filed by Natera against CareDx.

Yahoo | December 11, 2023

Read More 'NTRA' Stories Here

NTRA Price Returns

1-mo -7.63%
3-mo 27.89%
6-mo 109.07%
1-year 54.60%
3-year -20.25%
5-year 348.84%
YTD 36.14%
2023 55.94%
2022 -56.99%
2021 -6.16%
2020 195.40%
2019 141.33%

Continue Researching NTRA

Here are a few links from around the web to help you further your research on Natera Inc's stock as an investment opportunity:

Natera Inc (NTRA) Stock Price | Nasdaq
Natera Inc (NTRA) Stock Quote, History and News - Yahoo Finance
Natera Inc (NTRA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!